Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis
(2021)
Journal Article
Malaab, M., Renaud, L., Takamura, N., D Zimmerman, K., Abraham da Silveira, W., S Ramos, P., …A Feghali-Bostwick, C. (2021). Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Annals of the Rheumatic Diseases, 81(2), 268-277. https://doi.org/10.1136/annrheumdis-2021-221050
Objectives: Systemic sclerosis (SSc) is a complex disease of unknown aetiology in which inflammation and fibrosis lead to multiple organ damage. There is currently no effective therapy that can halt the progression of fibrosis or reverse it, thus stu... Read More about Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.